Over the counter medicines and the need for immediate action: a further evaluation of European Commission recommended wordings for communicating risk

被引:50
作者
Berry, D [1 ]
Raynor, T
Knapp, P
Bersellini, E
机构
[1] Univ Reading, Sch Psychol, Reading RG6 6AL, Berks, England
[2] Univ Leeds, Pharm Practice & Med Management Grp, Leeds LS2 9JT, W Yorkshire, England
关键词
risk communication; medicine side effects; over the counter medicines;
D O I
10.1016/S0738-3991(03)00111-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A study examined people's interpretation of European Commission (EC) recommended verbal descriptors for risk of medicine side effects, and actions to take if they do occur. Members of the general public were presented with a fictitious (but realistic) scenario about suffering from a stiff neck, visiting the local pharmacy and purchasing an over the counter (OTC) medicine (Ibruprofen). The medicine came with an information leaflet which included information about the medicine's side effects, their risk of occurrence, and recommended actions to take if adverse effects are experienced. Probability of occurrence was presented numerically (6%) or verbally, using the recommended EC descriptor (common). Results showed that, in line with findings of our earlier work with prescribed medicines, participants significantly overestimated side effect risk. Furthermore, the differences in interpretation were reflected in their judgements of satisfaction, side effect severity, risk to health, and intention to take the medicine. Finally, we observed no significant difference between people's interpretation of the recommended action descriptors ('immediately' and 'as soon as possible'). (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 16 条
[1]  
BENNETT P, 1998, COMMUNICATING RISKS
[2]   Provision of information about drug side-effects to patients [J].
Berry, DC ;
Knapp, P ;
Raynor, DK .
LANCET, 2002, 359 (9309) :853-854
[3]  
Berry DC., 2002, INT J PHARM PRACT, V10, P145, DOI [10.1111/j.2042-7174.2002.tb00602.x, DOI 10.1111/J.2042-7174.2002.TB00602.X]
[4]  
BERRY DC, IN PRESS PSYCHOL HLT
[5]  
*BRIT MED ASS ROYA, 2002, BRIT NAT FORM
[6]   Monitoring the safety of over the counter drugs - We need a better way than spontaneous reports [J].
Clark, D ;
Layton, D ;
Shakir, SAW .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7315) :706-707
[7]  
*DEP HLTH, 2000, NAT PLAN NHS
[8]   Patient information leaflets for medicines: using consumer testing to determine the most effective design [J].
Dickinson, D ;
Raynor, DK ;
Duman, M .
PATIENT EDUCATION AND COUNSELING, 2001, 43 (02) :147-159
[9]  
EEC, 1998, GUID READ LAB PACK L
[10]  
Fischer K, 1996, J BEHAV DECIS MAKING, V9, P153, DOI 10.1002/(SICI)1099-0771(199609)9:3<153::AID-BDM222>3.0.CO